查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1317958

人類胰島素製劑市場：按產品類型、品牌、藥物、輸送裝置、用途- 全球預測 2023-2030

Human Insulin Drugs Market by Product Type, Brands, Drugs, Delivery Devices, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年全球人類胰島素製劑市場將大幅成長至509.2億美元，年複合成長率為10.66%，預計2030年將達到驚人的1,039.7億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球人類胰島素製劑市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球人類胰島素製劑市場規模及預測為何？

2.在預測期內，COVID-19對全球人類胰島素製劑市場的阻礙因素與影響有哪些？

3. 在預測期內，全球人類胰島素製劑市場需要投資哪些產品/細分市場/用途/領域？

4.人類胰島素製劑全球市場的競爭策略是什麼？

5.全球人類胰島素製劑市場的技術趨勢與法律規範是什麼？

6.全球人類胰島素製劑市場主要廠商的市佔率是多少？

7. 哪些型態和策略措施被認為適合進入人類胰島素產品全球市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 全球糖尿病的盛行率正在上升
      • 老年人和肥胖人口顯著增加
      • 採用多種給藥方式
    • 抑制因素
      • 人類胰島素製劑高成本
    • 機會
      • 胰島素生物相似藥新法規
      • 持續投入人類胰島素產品研發
    • 任務
      • 嚴格的核准法規標準
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 人類胰島素製劑市場：依產品類型

  • 介紹
  • 基礎或長效胰島素
  • 胰島素生物相似藥
  • 混合胰島素
  • 速效胰島素
  • 常規人類胰島素

第7章 人類胰島素製劑市場：依品牌

  • 介紹
  • 優泌樂
  • 來得時
  • 諾和快速

第8章 人類胰島素製劑市場：依藥物分類

  • 介紹
  • 生物製品
  • 生物相似藥

第9章 人類胰島素製劑市場：依輸送裝置分類

  • 介紹
  • 筆針
  • 筆
  • 注射器

第10章 人類胰島素製劑市場：依用途

  • 介紹
  • 1型糖尿病
  • 2型糖尿病

第11章美洲人胰島素製劑市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太人胰島素製劑市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲人胰島素製劑市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第15章上市公司名單

第16章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-957C47F9223E

The Global Human Insulin Drugs Market is forecasted to grow significantly, with a projected USD 50.92 billion in 2023 at a CAGR of 10.66% and expected to reach a staggering USD 103.97 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Human Insulin Drugs Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Human Insulin Drugs Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product Type, market is studied across Basal or Long-Acting Insulins, Biosimilar Insulins, Combination Insulins, Fast-Acting Insulins, and Traditional Human Insulins. The Traditional Human Insulins is projected to witness significant market share during forecast period.

Based on Brands, market is studied across Humalog, Lantus, and NovoRapid. The Lantus is projected to witness significant market share during forecast period.

Based on Drugs, market is studied across Biologics and Biosimilars. The Biosimilars is projected to witness significant market share during forecast period.

Based on Delivery Devices, market is studied across Pen Needles, Pens, and Syringes. The Syringes is projected to witness significant market share during forecast period.

Based on Application, market is studied across Type 1 Diabetes and Type 2 Diabetes. The Type 1 Diabetes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Human Insulin Drugs Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Human Insulin Drugs Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Human Insulin Drugs Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Human Insulin Drugs Market?

4. What is the competitive strategic window for opportunities in the Global Human Insulin Drugs Market?

5. What are the technology trends and regulatory frameworks in the Global Human Insulin Drugs Market?

6. What is the market share of the leading vendors in the Global Human Insulin Drugs Market?

7. What modes and strategic moves are considered suitable for entering the Global Human Insulin Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Human Insulin Drugs Market, by Product Type, 2022 vs 2030
  • 4.3. Human Insulin Drugs Market, by Brands, 2022 vs 2030
  • 4.4. Human Insulin Drugs Market, by Drugs, 2022 vs 2030
  • 4.5. Human Insulin Drugs Market, by Delivery Devices, 2022 vs 2030
  • 4.6. Human Insulin Drugs Market, by Application, 2022 vs 2030
  • 4.7. Human Insulin Drugs Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of dibetic patient all over the globe
      • 5.1.1.2. Significant growth of geriatric and obese population
      • 5.1.1.3. Adoption of different drug delivery methods
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with human insulin drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. New regulations for insulin biosimilars
      • 5.1.3.2. Ongoing investments in R&D of human insulin drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory norms for approvals
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Human Insulin Drugs Market, by Product Type

  • 6.1. Introduction
  • 6.2. Basal or Long-Acting Insulins
  • 6.3. Biosimilar Insulins
  • 6.4. Combination Insulins
  • 6.5. Fast-Acting Insulins
  • 6.6. Traditional Human Insulins

7. Human Insulin Drugs Market, by Brands

  • 7.1. Introduction
  • 7.2. Humalog
  • 7.3. Lantus
  • 7.4. NovoRapid

8. Human Insulin Drugs Market, by Drugs

  • 8.1. Introduction
  • 8.2. Biologics
  • 8.3. Biosimilars

9. Human Insulin Drugs Market, by Delivery Devices

  • 9.1. Introduction
  • 9.2. Pen Needles
  • 9.3. Pens
  • 9.4. Syringes

10. Human Insulin Drugs Market, by Application

  • 10.1. Introduction
  • 10.2. Type 1 Diabetes
  • 10.3. Type 2 Diabetes

11. Americas Human Insulin Drugs Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Human Insulin Drugs Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Human Insulin Drugs Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player

15. List of Company Mentioned

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. HUMAN INSULIN DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. HUMAN INSULIN DRUGS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. HUMAN INSULIN DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
  • FIGURE 5. HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2022 VS 2030 (%)
  • FIGURE 6. HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2022 VS 2030 (%)
  • FIGURE 7. HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2022 VS 2030 (%)
  • FIGURE 8. HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 9. HUMAN INSULIN DRUGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 10. HUMAN INSULIN DRUGS MARKET DYNAMICS
  • FIGURE 11. HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 20. HUMAN INSULIN DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 21. HUMAN INSULIN DRUGS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. HUMAN INSULIN DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. HUMAN INSULIN DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. HUMAN INSULIN DRUGS MARKET SIZE, BY BASAL OR LONG-ACTING INSULINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. HUMAN INSULIN DRUGS MARKET SIZE, BY BIOSIMILAR INSULINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. HUMAN INSULIN DRUGS MARKET SIZE, BY COMBINATION INSULINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. HUMAN INSULIN DRUGS MARKET SIZE, BY FAST-ACTING INSULINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. HUMAN INSULIN DRUGS MARKET SIZE, BY TRADITIONAL HUMAN INSULINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 11. HUMAN INSULIN DRUGS MARKET SIZE, BY HUMALOG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. HUMAN INSULIN DRUGS MARKET SIZE, BY LANTUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. HUMAN INSULIN DRUGS MARKET SIZE, BY NOVORAPID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 15. HUMAN INSULIN DRUGS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. HUMAN INSULIN DRUGS MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 18. HUMAN INSULIN DRUGS MARKET SIZE, BY PEN NEEDLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. HUMAN INSULIN DRUGS MARKET SIZE, BY PENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. HUMAN INSULIN DRUGS MARKET SIZE, BY SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. HUMAN INSULIN DRUGS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. HUMAN INSULIN DRUGS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. HUMAN INSULIN DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 234. HUMAN INSULIN DRUGS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 235. HUMAN INSULIN DRUGS MARKET LICENSE & PRICING